20th International AIDS Conference - Melbourne, Australia


TUAB02 Challenges in Paediatrics: Taking Toddlers to Teens and Beyond
  Oral Abstract Session : Track B
Venue: Melbourne Room 1
Time: 22.07.2014, 14:30 - 16:00
Co-Chairs: Dorothy Mbori-Ngacha, UNICEF
Carlo Giaquinto, Italy

14:30
TUAB0201
Powerpoint
Webcast
Introduction
L. Mofenson, United States

14:40
TUAB0202
Abstract
Powerpoint
Webcast
HIV antibody detection in children who started antiretroviral treatment in infancy
L. Kuhn1, D. Schramm2, S. Shiau1, R. Strehlau3, M. Paximadis2, F. Pinillos3, K. Technau3, L. Martens3, A. Coovadia3, E. Abrams1, A. Puren2, C. Tiemessen2
1Columbia University, New York, United States, 2National Institute of Communicable Diseases, Johannesburg, South Africa, 3Rahima Moosa Mother and Child Hospital, Johannesburg, South Africa

14:52
TUAB0203
Abstract
Powerpoint
Webcast
High prevalence of PLIN gene and metabolic risk factors among children initiating antiretroviral therapy in south India
P. Chandrasekaran1, A. Shet2, K. Ramesh1, P.K. Bhavani1, R. Srinivasan1, G. Sanjeeva3, P. Gangadevi1, E. Suresh4, C. Chandrasekar5, C. Wanke6, S. Swaminathan1
1National Institute for Research in Tuberculosis (ICMR), Chennai, India, 2St. John's Medical College Hospital, Bangalore, India, 3Indira Gandhi Institute of Child Health, Bangalore, India, 4Institute of Child Health and Government Hospital for Children, Chennai, India, 5Government Hospital of Thoracic Medicine, Chennai, India, 6Tufts University School of Medicine, Boston, United States

15:04
TUAB0204
Abstract
Powerpoint
Webcast
Retention across the continuum of care of HIV infected children in rural India
G. Alvarez-Uria
RDT Hospital Bathalapalli, Infectious Diseases, Bathalapalli, India

15:16
TUAB0205
Abstract
Powerpoint
Webcast
HIV treatment outcomes of pediatric patients starting antiretroviral treatment (ART) from childhood through to late adolescence: impact of age at ART initiation on outcomes
L. Nganga1, F. Odhiambo2, S. Ojoo2, H. Ooko1, C. Githu1, D. Wandina2, R. Ngethe1, L. Burrows3
1Futures Group International, Nairobi, Kenya, 2University of Maryland, Nairobi, Kenya, 3Futures Group International, Washington DC, United States

15:28
TUAB0206LB
Abstract
Powerpoint
Webcast
Impact of early initiation of combination antiretroviral therapy on measures of virus in peripheral blood of vertically HIV-1-infected children
J. Brophy1, T.-W. Chun2, L. Samson1, F. Kakkar3, H. Soudeyns3, M. Ostrowski4, S. Mujib5, J. Kim6, P. Sandstrom6, R. Harrigan7, S. Read8, A. Bitnun8
1Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, Canada, 2National Institute of Allergy & Infectious Diseases, National Institutes of Health, Bethesda, United States, 3Centre Hospitalier Universitaire - Ste-Justine, Universite de Montreal, Montreal, Canada, 4University of Toronto, Department of Immunology and Medicine, Toronto, Canada, 5University of Toronto, Institute of Medical Sciences, Department of Medicine, Toronto, Canada, 6Public Health Agency of Canada, National HIV & Retrovirology Laboratories, Toronto, Canada, 7University of British Columbia, British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada, 8The Hospital for Sick Children, University of Toronto, Toronto, Canada

15:43
TUAB0207
Webcast
Moderated discussion

Powerpoints presentations
Introduction - Lynne Mofenson

HIV antibody detection in children who started antiretroviral treatment in infancy - Louise Kuhn

High prevalence of PLIN gene and metabolic risk factors among children initiating antiretroviral therapy in south India - Padmapriyadarsini Chandrasekaran

Retention across the continuum of care of HIV infected children in rural India - Gerardo Alvarez-Uria

HIV treatment outcomes of pediatric patients starting antiretroviral treatment (ART) from childhood through to late adolescence: impact of age at ART initiation on outcomes - Lucy Nganga

Impact of early initiation of combination antiretroviral therapy on measures of virus in peripheral blood of vertically HIV-1-infected children - Jason Brophy



   

    The organizers reserve the right to amend the programme.